C4 Therapeutics has appointed Adam Crystal as chief medical officer.
Dr Crystal was previously at the Novartis Institutes for BioMedical Research, working on early development programs in oncology.
Executive chairman Marc Cohen said: “Adam expands C4T’s leadership team at an important stage of the company’s growth as we move to bring this new mode of medicine into the clinic over the next two years.”
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze